Fisher Asset Management
RVMD icon

Fisher Asset Management’s Revolution Medicines RVMD Stock Holding History

Fisher Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9M Sell
207,693
-8,254
-4% -$1.21M 0.01% 262
2026
Q1 		$21M Sell
215,947
-25,110
-10% -$2.54M 0.01% 323
2025
Q4 		$19.2M Buy
241,057
+233,752
+3,200% +$15.3M 0.01% 328
2025
Q3 		$341K Buy
+7,305
New +$286K ﹤0.01% 858

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fisher Asset Management's RVMD Position: Q2 2026 in Review

Fisher Asset Management reduced its Revolution Medicines (RVMD) stake by 3.8% in Q2 2026, selling an estimated $1.21M and leaving 207,693 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #262.

Fisher Asset Management first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fisher Asset Management held 207,693 shares of Revolution Medicines worth $38.9M as of Q2 2026.
  • Fisher Asset Management sold 8,254 Revolution Medicines shares in Q2 2026, an estimated $1.21M.
  • Revolution Medicines made up 0.01% of Fisher Asset Management's portfolio in Q2 2026, its #262 holding.
  • Fisher Asset Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.